Skip to main content
Veterinary Medicines

COGLAMUNE

Not authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid

Product identification

Medicine name:
КОГЛАМУН
COGLAMUNE
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
Target species:
  • Sheep
  • Goat
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
    • Goat
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Authorisation status:
  • Surrendered
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Animal Health Bulgaria EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-1318
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 25/08/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 25/08/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 25/08/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."